# Centene Corp: Form 10-Q for the period ended Mar 31, 2021

- Company: [Centene Corp](/companies/cnc.md) (CIK 1071739)
- Form: 10-Q
- Filed: 2021-04-27
- Accepted by EDGAR: Apr 27, 2021, 00:55 ET
- Period: 2021-03-31
- Accession: 0001071739-21-000092
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1071739/000107173921000092/cnc-20210331.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1071739/000107173921000092/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2021-03-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2021-01-01 to 2021-03-31 | $28.11bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months, 2021-01-01 to 2021-03-31 | $1.05bn | us-gaap:CostOfGoodsAndServicesSold |
| Selling, general and administrative | 3 months, 2021-01-01 to 2021-03-31 | $2.37bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2021-01-01 to 2021-03-31 | $1.05bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2021-01-01 to 2021-03-31 | $170.0m | us-gaap:InterestExpense |
| Income tax | 3 months, 2021-01-01 to 2021-03-31 | $244.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2021-01-01 to 2021-03-31 | $699.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2021-01-01 to 2021-03-31 | $1.19 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2021-01-01 to 2021-03-31 | $1.20 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2021-01-01 to 2021-03-31 | 589,343,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months, 2021-01-01 to 2021-03-31 | $43.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months, 2021-01-01 to 2021-03-31 | $187.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 3 months, 2021-01-01 to 2021-03-31 | $29.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2021-03-31 | $9.63bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2021-03-31 | $24.44bn | us-gaap:AssetsCurrent |
| Total assets | at 2021-03-31 | $70.28bn | us-gaap:Assets |
| Current liabilities | at 2021-03-31 | $22.28bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2021-03-31 | $43.75bn | us-gaap:Liabilities |
| Long-term debt | at 2021-03-31 | $16.70bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2021-03-31 | $62.0m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | at 2021-03-31 | $26.34bn | us-gaap:StockholdersEquity |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1071739/000107173921000092/cnc-20210331.htm

Filed Apr 27, 2021.
Source: SEC EDGAR, the filing index for accession 0001071739-21-000092. Last ingested by Listed: Oct 24, 2026, 15:03 ET. No prices; not investment advice.
